Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Taro Pharmaceutical Industries Revenue 2010-2023 | TARO

Taro Pharmaceutical Industries revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Taro Pharmaceutical Industries Annual Revenue
(Millions of US $)
2023 $573
2022 $561
2021 $549
2020 $645
2019 $670
2018 $662
2017 $879
2016 $951
2015 $863
2014 $759
2013 $671
2012 $145
2011 $
2011 $108
2010 $
2010 $89
2009 $
Taro Pharmaceutical Industries Quarterly Revenue
(Millions of US $)
2023-12-31 $157
2023-09-30 $148
2023-06-30 $159
2023-03-31 $147
2022-12-31 $139
2022-09-30 $130
2022-06-30 $157
2022-03-31 $143
2021-12-31 $139
2021-09-30 $132
2021-06-30 $147
2021-03-31 $148
2020-12-31 $140
2020-09-30 $143
2020-06-30 $118
2020-03-31 $175
2019-12-31 $148
2019-09-30 $161
2019-06-30 $161
2019-03-31 $180
2018-12-31 $176
2018-09-30 $159
2018-06-30 $155
2018-03-31 $175
2017-12-31 $155
2017-09-30 $170
2017-06-30 $161
2017-03-31 $196
2016-12-31 $220
2016-09-30 $229
2016-06-30 $234
2016-03-31 $265
2015-12-31 $258
2015-09-30 $212
2015-06-30 $215
2015-03-31 $244
2014-12-31 $238
2014-09-30 $251
2014-06-30 $130
2014-03-31 $187
2013-12-31 $214
2013-09-30 $205
2013-06-30 $153
2013-03-31 $165
2012-12-31 $186
2012-09-30 $161
2012-06-30 $159
2012-03-31 $145
2011-12-31 $148
2011-09-30 $138
2011-06-30 $112
2011-03-31 $108
2010-12-31 $102
2010-09-30 $103
2010-06-30 $98
2010-03-31 $89
2009-12-31 $85
2009-09-30 $94
2009-06-30 $97
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.592B $0.573B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.067B 32.15
Chugai Pharmaceutical (CHGCY) Japan $51.455B 23.00
Takeda Pharmaceutical (TAK) Japan $42.377B 8.58
Merck (MKGAF) Germany $22.694B 22.00
Astellas Pharma (ALPMY) Japan $17.735B 28.00
Sandoz Group AG (SDZNY) Switzerland $15.417B 0.00
Neurocrine Biosciences (NBIX) United States $14.290B 39.12
Shionogi (SGIOY) Japan $13.866B 12.05
United Therapeutics (UTHR) United States $12.095B 12.89
Catalent (CTLT) United States $10.064B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.683B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.918B 7.61
Revolution Medicines (RVMD) United States $6.499B 0.00
Ionis Pharmaceuticals (IONS) United States $5.723B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.512B 0.00
Alpine Immune Sciences (ALPN) United States $4.457B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.982B 0.00
Summit Therapeutics (SMMT) United States $3.152B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.110B 0.00
Corcept Therapeutics (CORT) United States $2.897B 26.25
PTC Therapeutics (PTCT) United States $2.582B 0.00
Dyne Therapeutics (DYN) United States $2.567B 0.00
Indivior (INDV) United States $2.416B 11.45
Recursion Pharmaceuticals (RXRX) United States $2.349B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.109B 12.05
Evotec AG (EVO) Germany $2.009B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.968B 19.15
Fusion Pharmaceuticals (FUSN) Canada $1.832B 0.00
Ardelyx (ARDX) United States $1.827B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.768B 0.00
Soleno Therapeutics (SLNO) United States $1.511B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.457B 0.00
Pacira BioSciences (PCRX) United States $1.400B 13.31
4D Molecular Therapeutics (FDMT) United States $1.323B 0.00
Xencor (XNCR) United States $1.313B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.313B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.112B 6.65
Cronos Group (CRON) Canada $1.108B 0.00
Cassava Sciences (SAVA) United States $1.104B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.027B 16.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.994B 0.00
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.913B 14.93
Relay Therapeutics (RLAY) United States $0.902B 0.00
ProKidney (PROK) United States $0.899B 0.00
ARS Pharmaceuticals (SPRY) United States $0.860B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.758B 0.00
Sage Therapeutics (SAGE) United States $0.705B 0.00
Silence Therapeutics (SLN) United Kingdom $0.668B 0.00
Savara (SVRA) United States $0.667B 0.00
Lyell Immunopharma (LYEL) United States $0.665B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.659B 0.00
Altimmune (ALT) United States $0.629B 0.00
Exscientia (EXAI) United Kingdom $0.620B 0.00
Harrow (HROW) United States $0.563B 0.00
Siga Technologies (SIGA) United States $0.555B 7.09
OmniAb (OABI) United States $0.532B 0.00
Verve Therapeutics (VERV) United States $0.523B 0.00
KalVista Pharmaceuticals (KALV) United States $0.507B 0.00
Bioventus (BVS) United States $0.503B 19.24
Larimar Therapeutics (LRMR) United States $0.502B 0.00
Korro Bio (KRRO) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.478B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
Lexeo Therapeutics (LXEO) United States $0.460B 0.00
Heron Therapeutics (HRTX) United States $0.452B 0.00
Esperion Therapeutics (ESPR) United States $0.436B 0.00
Organogenesis (ORGO) United States $0.394B 74.25
Tourmaline Bio (TRML) United States $0.391B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.386B 0.00
Nanobiotix S.A (NBTX) France $0.345B 0.00
Fractyl Health (GUTS) United States $0.342B 0.00
Nektar Therapeutics (NKTR) United States $0.336B 0.00
Black Diamond Therapeutics (BDTX) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 18.76
Xeris Biopharma Holdings (XERS) United States $0.294B 0.00
Aquestive Therapeutics (AQST) United States $0.293B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.283B 0.00
ESSA Pharma (EPIX) Canada $0.275B 0.00
Metagenomi (MGX) United States $0.255B 0.00
Pyxis Oncology (PYXS) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.248B 0.00
Akebia Therapeutics (AKBA) United States $0.247B 0.00
Foghorn Therapeutics (FHTX) United States $0.225B 0.00
Eliem Therapeutics (ELYM) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Profound Medical (PROF) Canada $0.209B 0.00
Zevra Therapeutics (ZVRA) United States $0.202B 0.00
Century Therapeutics (IPSC) United States $0.200B 0.00
Acrivon Therapeutics (ACRV) United States $0.196B 0.00
Adherex Technologies (FENC) United States $0.191B 232.67
Galectin Therapeutics (GALT) United States $0.189B 0.00
Incannex Healthcare (IXHL) Australia $0.184B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Achieve Life Sciences (ACHV) Canada $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.170B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Prelude Therapeutics (PRLD) United States $0.168B 0.00
VAXART, INC (VXRT) United States $0.167B 0.00
CytoDyn (CYDY) United States $0.164B 0.00
Cardiol Therapeutics (CRDL) Canada $0.158B 0.00
Elite Pharmaceuticals (ELTP) United States $0.149B 13.99
OptiNose (OPTN) United States $0.134B 0.00
Karyopharm Therapeutics (KPTI) United States $0.133B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Context Therapeutics (CNTX) United States $0.127B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.124B 8.27
FibroGen (FGEN) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
PMV Pharmaceuticals (PMVP) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.105B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.20
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Protara Therapeutics (TARA) United States $0.076B 0.00
Tempest Therapeutics (TPST) United States $0.075B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Jaguar Animal Health (JAGX) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.065B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Nutriband (NTRB) United States $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
Unicycive Therapeutics (UNCY) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Rafael Holdings (RFL) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
NRx Pharmaceuticals (NRXP) United States $0.035B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
JanOne (JAN) United States $0.031B 0.00
Lipocine (LPCN) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Talphera (TLPH) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
CERo Therapeutics Holdings (CERO) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.015B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Inhibikase Therapeutics (IKT) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.78